Global and United States Sustained Release Ocular Drug Delivery Systems Market Report & Forecast 2022-2028

Publisher Name :
Date: 06-Jun-2022
No. of pages: 108
Inquire Before Buying

Sustained Release Ocular Drug Delivery Systems market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Sustained Release Ocular Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Sustained Release Ocular Drug Delivery Systems market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

- Liposome

- Microcapsules/Nanocapsules

- Microspheres/Nanosptheres

- Implants

Segment by Application

- Cataract

- Glaucoma

- Corneal Transplantation

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- pSivida

- Allergan

- Icon Bioscience

- Ocular Therapeutix

- Neurotech Pharmaceuticals

- Santen Pharmaceutical

- Aciont Inc.

- Envisia Therapeutics

- GrayBug

- Innocore Pharmaceuticals

- OHR Pharmaceuticals

- PolyActiva

- TheraKine

Global and United States Sustained Release Ocular Drug Delivery Systems Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Sustained Release Ocular Drug Delivery Systems Product Introduction
1.2 Global Sustained Release Ocular Drug Delivery Systems Outlook 2017 VS 2022 VS 2028
1.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales in US$ Million for the Year 2017-2028
1.2.2 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume for the Year 2017-2028
1.3 United States Sustained Release Ocular Drug Delivery Systems Outlook 2017 VS 2022 VS 2028
1.3.1 United States Sustained Release Ocular Drug Delivery Systems Sales in US$ Million for the Year 2017-2028
1.3.2 United States Sustained Release Ocular Drug Delivery Systems Sales in Volume for the Year 2017-2028
1.4 Sustained Release Ocular Drug Delivery Systems Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Sustained Release Ocular Drug Delivery Systems in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Sustained Release Ocular Drug Delivery Systems Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Sustained Release Ocular Drug Delivery Systems Market Dynamics
1.5.1 Sustained Release Ocular Drug Delivery Systems Industry Trends
1.5.2 Sustained Release Ocular Drug Delivery Systems Market Drivers
1.5.3 Sustained Release Ocular Drug Delivery Systems Market Challenges
1.5.4 Sustained Release Ocular Drug Delivery Systems Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Sustained Release Ocular Drug Delivery Systems Market Segment by Type
2.1.1 Liposome
2.1.2 Microcapsules/Nanocapsules
2.1.3 Microspheres/Nanosptheres
2.1.4 Implants
2.2 Global Sustained Release Ocular Drug Delivery Systems Market Size by Type
2.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Sustained Release Ocular Drug Delivery Systems Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Sustained Release Ocular Drug Delivery Systems Market Size by Type
2.3.1 United States Sustained Release Ocular Drug Delivery Systems Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Sustained Release Ocular Drug Delivery Systems Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Sustained Release Ocular Drug Delivery Systems Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Sustained Release Ocular Drug Delivery Systems Market Segment by Application
3.1.1 Cataract
3.1.2 Glaucoma
3.1.3 Corneal Transplantation
3.1.4 Others
3.2 Global Sustained Release Ocular Drug Delivery Systems Market Size by Application
3.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Sustained Release Ocular Drug Delivery Systems Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Sustained Release Ocular Drug Delivery Systems Market Size by Application
3.3.1 United States Sustained Release Ocular Drug Delivery Systems Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Sustained Release Ocular Drug Delivery Systems Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Sustained Release Ocular Drug Delivery Systems Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Sustained Release Ocular Drug Delivery Systems Competitor Landscape by Company
4.1 Global Sustained Release Ocular Drug Delivery Systems Market Size by Company
4.1.1 Top Global Sustained Release Ocular Drug Delivery Systems Manufacturers Ranked by Revenue (2021)
4.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Manufacturer (2017-2022)
4.1.3 Global Sustained Release Ocular Drug Delivery Systems Sales by Manufacturer (2017-2022)
4.1.4 Global Sustained Release Ocular Drug Delivery Systems Price by Manufacturer (2017-2022)
4.2 Global Sustained Release Ocular Drug Delivery Systems Concentration Ratio (CR)
4.2.1 Sustained Release Ocular Drug Delivery Systems Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Sustained Release Ocular Drug Delivery Systems in 2021
4.2.3 Global Sustained Release Ocular Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Sustained Release Ocular Drug Delivery Systems Manufacturing Base Distribution, Product Type
4.3.1 Global Sustained Release Ocular Drug Delivery Systems Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Sustained Release Ocular Drug Delivery Systems Product Type
4.3.3 Date of International Manufacturers Enter into Sustained Release Ocular Drug Delivery Systems Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Sustained Release Ocular Drug Delivery Systems Market Size by Company
4.5.1 Top Sustained Release Ocular Drug Delivery Systems Players in United States, Ranked by Revenue (2021)
4.5.2 United States Sustained Release Ocular Drug Delivery Systems Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Sustained Release Ocular Drug Delivery Systems Sales by Players (2020, 2021 & 2022)
5 Global Sustained Release Ocular Drug Delivery Systems Market Size by Region
5.1 Global Sustained Release Ocular Drug Delivery Systems Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Sustained Release Ocular Drug Delivery Systems Market Size in Volume by Region (2017-2028)
5.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume by Region: 2017-2022
5.2.2 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume Forecast by Region (2023-2028)
5.3 Global Sustained Release Ocular Drug Delivery Systems Market Size in Value by Region (2017-2028)
5.3.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Value by Region: 2017-2022
5.3.2 Global Sustained Release Ocular Drug Delivery Systems Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Sustained Release Ocular Drug Delivery Systems Market Size YoY Growth 2017-2028
6.1.2 North America Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Sustained Release Ocular Drug Delivery Systems Market Size YoY Growth 2017-2028
6.3.2 Europe Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Sustained Release Ocular Drug Delivery Systems Market Size YoY Growth 2017-2028
6.4.2 Latin America Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 pSivida
7.1.1 pSivida Corporation Information
7.1.2 pSivida Description and Business Overview
7.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.1.4 pSivida Sustained Release Ocular Drug Delivery Systems Products Offered
7.1.5 pSivida Recent Development
7.2 Allergan
7.2.1 Allergan Corporation Information
7.2.2 Allergan Description and Business Overview
7.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Allergan Sustained Release Ocular Drug Delivery Systems Products Offered
7.2.5 Allergan Recent Development
7.3 Icon Bioscience
7.3.1 Icon Bioscience Corporation Information
7.3.2 Icon Bioscience Description and Business Overview
7.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Products Offered
7.3.5 Icon Bioscience Recent Development
7.4 Ocular Therapeutix
7.4.1 Ocular Therapeutix Corporation Information
7.4.2 Ocular Therapeutix Description and Business Overview
7.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Products Offered
7.4.5 Ocular Therapeutix Recent Development
7.5 Neurotech Pharmaceuticals
7.5.1 Neurotech Pharmaceuticals Corporation Information
7.5.2 Neurotech Pharmaceuticals Description and Business Overview
7.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Products Offered
7.5.5 Neurotech Pharmaceuticals Recent Development
7.6 Santen Pharmaceutical
7.6.1 Santen Pharmaceutical Corporation Information
7.6.2 Santen Pharmaceutical Description and Business Overview
7.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Products Offered
7.6.5 Santen Pharmaceutical Recent Development
7.7 Aciont Inc.
7.7.1 Aciont Inc. Corporation Information
7.7.2 Aciont Inc. Description and Business Overview
7.7.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Products Offered
7.7.5 Aciont Inc. Recent Development
7.8 Envisia Therapeutics
7.8.1 Envisia Therapeutics Corporation Information
7.8.2 Envisia Therapeutics Description and Business Overview
7.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Products Offered
7.8.5 Envisia Therapeutics Recent Development
7.9 GrayBug
7.9.1 GrayBug Corporation Information
7.9.2 GrayBug Description and Business Overview
7.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.9.4 GrayBug Sustained Release Ocular Drug Delivery Systems Products Offered
7.9.5 GrayBug Recent Development
7.10 Innocore Pharmaceuticals
7.10.1 Innocore Pharmaceuticals Corporation Information
7.10.2 Innocore Pharmaceuticals Description and Business Overview
7.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Products Offered
7.10.5 Innocore Pharmaceuticals Recent Development
7.11 OHR Pharmaceuticals
7.11.1 OHR Pharmaceuticals Corporation Information
7.11.2 OHR Pharmaceuticals Description and Business Overview
7.11.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.11.4 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Products Offered
7.11.5 OHR Pharmaceuticals Recent Development
7.12 PolyActiva
7.12.1 PolyActiva Corporation Information
7.12.2 PolyActiva Description and Business Overview
7.12.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.12.4 PolyActiva Products Offered
7.12.5 PolyActiva Recent Development
7.13 TheraKine
7.13.1 TheraKine Corporation Information
7.13.2 TheraKine Description and Business Overview
7.13.3 TheraKine Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.13.4 TheraKine Products Offered
7.13.5 TheraKine Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Sustained Release Ocular Drug Delivery Systems Industry Chain Analysis
8.2 Sustained Release Ocular Drug Delivery Systems Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Sustained Release Ocular Drug Delivery Systems Distributors
8.3 Sustained Release Ocular Drug Delivery Systems Production Mode & Process
8.4 Sustained Release Ocular Drug Delivery Systems Sales and Marketing
8.4.1 Sustained Release Ocular Drug Delivery Systems Sales Channels
8.4.2 Sustained Release Ocular Drug Delivery Systems Distributors
8.5 Sustained Release Ocular Drug Delivery Systems Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Sustained Release Ocular Drug Delivery Systems CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Sustained Release Ocular Drug Delivery Systems Market Trends
Table 3. Sustained Release Ocular Drug Delivery Systems Market Drivers
Table 4. Sustained Release Ocular Drug Delivery Systems Market Challenges
Table 5. Sustained Release Ocular Drug Delivery Systems Market Restraints
Table 6. Global Sustained Release Ocular Drug Delivery Systems Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Sustained Release Ocular Drug Delivery Systems Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Sustained Release Ocular Drug Delivery Systems Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Sustained Release Ocular Drug Delivery Systems Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Sustained Release Ocular Drug Delivery Systems Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Sustained Release Ocular Drug Delivery Systems Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Manufacturer, 2017-2022
Table 13. Global Sustained Release Ocular Drug Delivery Systems Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Manufacturer, 2017-2022
Table 15. Global Sustained Release Ocular Drug Delivery Systems Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Sustained Release Ocular Drug Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Sustained Release Ocular Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained Release Ocular Drug Delivery Systems as of 2021)
Table 18. Top Players of Sustained Release Ocular Drug Delivery Systems in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Sustained Release Ocular Drug Delivery Systems Product Type
Table 20. Date of International Manufacturers Enter into Sustained Release Ocular Drug Delivery Systems Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Sustained Release Ocular Drug Delivery Systems Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Sustained Release Ocular Drug Delivery Systems Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Sustained Release Ocular Drug Delivery Systems Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Sustained Release Ocular Drug Delivery Systems Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Sustained Release Ocular Drug Delivery Systems Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Sustained Release Ocular Drug Delivery Systems Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Sustained Release Ocular Drug Delivery Systems Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Sustained Release Ocular Drug Delivery Systems Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Sustained Release Ocular Drug Delivery Systems Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Sustained Release Ocular Drug Delivery Systems Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. pSivida Corporation Information
Table 43. pSivida Description and Business Overview
Table 44. pSivida Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. pSivida Sustained Release Ocular Drug Delivery Systems Product
Table 46. pSivida Recent Development
Table 47. Allergan Corporation Information
Table 48. Allergan Description and Business Overview
Table 49. Allergan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Allergan Product
Table 51. Allergan Recent Development
Table 52. Icon Bioscience Corporation Information
Table 53. Icon Bioscience Description and Business Overview
Table 54. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Icon Bioscience Product
Table 56. Icon Bioscience Recent Development
Table 57. Ocular Therapeutix Corporation Information
Table 58. Ocular Therapeutix Description and Business Overview
Table 59. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Ocular Therapeutix Product
Table 61. Ocular Therapeutix Recent Development
Table 62. Neurotech Pharmaceuticals Corporation Information
Table 63. Neurotech Pharmaceuticals Description and Business Overview
Table 64. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Neurotech Pharmaceuticals Product
Table 66. Neurotech Pharmaceuticals Recent Development
Table 67. Santen Pharmaceutical Corporation Information
Table 68. Santen Pharmaceutical Description and Business Overview
Table 69. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. Santen Pharmaceutical Product
Table 71. Santen Pharmaceutical Recent Development
Table 72. Aciont Inc. Corporation Information
Table 73. Aciont Inc. Description and Business Overview
Table 74. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. Aciont Inc. Product
Table 76. Aciont Inc. Recent Development
Table 77. Envisia Therapeutics Corporation Information
Table 78. Envisia Therapeutics Description and Business Overview
Table 79. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. Envisia Therapeutics Product
Table 81. Envisia Therapeutics Recent Development
Table 82. GrayBug Corporation Information
Table 83. GrayBug Description and Business Overview
Table 84. GrayBug Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. GrayBug Product
Table 86. GrayBug Recent Development
Table 87. Innocore Pharmaceuticals Corporation Information
Table 88. Innocore Pharmaceuticals Description and Business Overview
Table 89. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Innocore Pharmaceuticals Product
Table 91. Innocore Pharmaceuticals Recent Development
Table 92. OHR Pharmaceuticals Corporation Information
Table 93. OHR Pharmaceuticals Description and Business Overview
Table 94. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. OHR Pharmaceuticals Product
Table 96. OHR Pharmaceuticals Recent Development
Table 97. PolyActiva Corporation Information
Table 98. PolyActiva Description and Business Overview
Table 99. PolyActiva Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. PolyActiva Product
Table 101. PolyActiva Recent Development
Table 102. TheraKine Corporation Information
Table 103. TheraKine Description and Business Overview
Table 104. TheraKine Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 105. TheraKine Product
Table 106. TheraKine Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Sustained Release Ocular Drug Delivery Systems Customers List
Table 110. Sustained Release Ocular Drug Delivery Systems Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Sustained Release Ocular Drug Delivery Systems Product Picture
Figure 2. Global Sustained Release Ocular Drug Delivery Systems Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Sustained Release Ocular Drug Delivery Systems Market Size 2017-2028 (US$ Million)
Figure 4. Global Sustained Release Ocular Drug Delivery Systems Sales 2017-2028 (K Pcs)
Figure 5. United States Sustained Release Ocular Drug Delivery Systems Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Sustained Release Ocular Drug Delivery Systems Market Size 2017-2028 (US$ Million)
Figure 7. United States Sustained Release Ocular Drug Delivery Systems Sales 2017-2028 (K Pcs)
Figure 8. United States Sustained Release Ocular Drug Delivery Systems Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Sustained Release Ocular Drug Delivery Systems Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Sustained Release Ocular Drug Delivery Systems Report Years Considered
Figure 11. Product Picture of Liposome
Figure 12. Product Picture of Microcapsules/Nanocapsules
Figure 13. Product Picture of Microspheres/Nanosptheres
Figure 14. Product Picture of Implants
Figure 15. Global Sustained Release Ocular Drug Delivery Systems Market Share by Type in 2022 & 2028
Figure 16. Global Sustained Release Ocular Drug Delivery Systems Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2028) & (K Pcs)
Figure 19. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Sustained Release Ocular Drug Delivery Systems Price by Type (2017-2028) & (USD/Pcs)
Figure 21. United States Sustained Release Ocular Drug Delivery Systems Market Share by Type in 2022 & 2028
Figure 22. United States Sustained Release Ocular Drug Delivery Systems Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2028) & (K Pcs)
Figure 25. United States Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Sustained Release Ocular Drug Delivery Systems Price by Type (2017-2028) & (USD/Pcs)
Figure 27. Product Picture of Cataract
Figure 28. Product Picture of Glaucoma
Figure 29. Product Picture of Corneal Transplantation
Figure 30. Product Picture of Others
Figure 31. Global Sustained Release Ocular Drug Delivery Systems Market Share by Application in 2022 & 2028
Figure 32. Global Sustained Release Ocular Drug Delivery Systems Sales in Value by Application (2017-2028) & (US$ Million)
Figure 33. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Application (2017-2028)
Figure 34. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2028) & (K Pcs)
Figure 35. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Application (2017-2028)
Figure 36. Global Sustained Release Ocular Drug Delivery Systems Price by Application (2017-2028) & (USD/Pcs)
Figure 37. United States Sustained Release Ocular Drug Delivery Systems Market Share by Application in 2022 & 2028
Figure 38. United States Sustained Release Ocular Drug Delivery Systems Sales in Value by Application (2017-2028) & (US$ Million)
Figure 39. United States Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Application (2017-2028)
Figure 40. United States Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2028) & (K Pcs)
Figure 41. United States Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Application (2017-2028)
Figure 42. United States Sustained Release Ocular Drug Delivery Systems Price by Application (2017-2028) & (USD/Pcs)
Figure 43. North America Sustained Release Ocular Drug Delivery Systems Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 44. North America Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. U.S. Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Canada Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. Europe Sustained Release Ocular Drug Delivery Systems Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 48. Europe Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 49. Germany Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. France Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. U.K. Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Italy Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Russia Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 55. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 56. China Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Japan Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. South Korea Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. India Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Australia Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Taiwan Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Indonesia Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Thailand Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Malaysia Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Philippines Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Latin America Sustained Release Ocular Drug Delivery Systems Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 67. Latin America Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 68. Mexico Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Brazil Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Argentina Sustained Release Ocular Drug Delivery Systems Sales in
  • Global Artificial Tears Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 91
    Artificial tears are lubricant eye drops used to treat The dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. The global Artificial Tears market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 5240.1 million by 2030, witnessing a CAGR of 8.6% during The forecast period 2024-2030. The industry's leading producers are Aller......
  • Global Contact Lens Solution Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 96
    Contact lens solution is a kind of solution that is used to contact lens with The function of cleaning, disinfection, rinsing or preservation, it can also alleviate The eyeball discomfort which caused by wear The contact lens. Contact lens solution can direct contact eyeball, so it must be accord with industrial standard. The global Contact Lens Solution market was valued at US$ 4087.6 million in 2023 and is anticipated to reach US$ 5323.5 million by 2030, witnessing a CAGR of 3.8% ......
  • Global Latanoprost Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 82
    Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside The eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside The eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in The body (prostaglandin) and works by regulating The flow of fluid within The eye which results in lower pressure. Lowerin......
  • Global Contact Lens Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Contact Lens Solution market: According to our latest research, the global Contact Lens Solution market looks promising in the next 5 years. As of 2022, the global Contact Lens Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Contact ......
  • Global Dry Eye Syndrome Drugs Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive......
  • Global Eye Drops & Lubricants Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Eye Drops & Lubricants market size was valued at US$ 8841.8 million in 2023. With growing demand in downstream market, the Eye Drops & Lubricants is forecast to a readjusted size of US$ 9780.8 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential of the global Eye Drops & Lubricants market. Eye Drops & Lubricants are expected to show stable growth in the future market. H......
  • Global Conjunctivitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Conjunctivitis market size was valued at US$ 3482.7 million in 2023. With growing demand in downstream market, the Conjunctivitis is forecast to a readjusted size of US$ 3908 million by 2030 with a CAGR of 1.7% during review period. The research report highlights the growth potential of the global Conjunctivitis market. Conjunctivitis are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Contact Lens Solution Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118
    According to our LPI (LP Information) latest study, the global Contact Lens Solution market size was valued at US$ 3998.7 million in 2023. With growing demand in downstream market, the Contact Lens Solution is forecast to a readjusted size of US$ 5241.5 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Contact Lens Solution market. Contact Lens Solution are expected to show stable growth in the future market. Howev......
  • Global Latanoprost Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Latanoprost market size was valued at US$ 1344.2 million in 2023. With growing demand in downstream market, the Latanoprost is forecast to a readjusted size of US$ 1574.2 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Latanoprost market. Latanoprost are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs